Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008;3(10):e3571.
doi: 10.1371/journal.pone.0003571. Epub 2008 Oct 29.

Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum

Affiliations

Acquisition of growth-inhibitory antibodies against blood-stage Plasmodium falciparum

Fiona J McCallum et al. PLoS One. 2008.

Abstract

Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood.

Methods: We tested dialysed serum and purified immunoglobulins from Kenyan children and adults for inhibition of P. falciparum blood-stage growth in vitro using different parasite lines. Serum antibodies were measured by ELISA to blood-stage parasite antigens, extracted from P. falciparum schizonts, and to recombinant merozoite surface protein 1 (42 kDa C-terminal fragment, MSP1-42).

Results: Antibodies to blood-stage antigens present in schizont protein extract and to recombinant MSP1-42 significantly increased with age and were highly correlated. In contrast, growth-inhibitory activity was not strongly associated with age and tended to decline marginally with increasing age and exposure, with young children demonstrating the highest inhibitory activity. Comparison of growth-inhibitory activity among samples collected from the same population at different time points suggested that malaria transmission intensity influenced the level of growth-inhibitory antibodies. Antibodies to recombinant MSP1-42 were not associated with growth inhibition and high immunoglobulin G levels were poorly predictive of inhibitory activity. The level of inhibitory activity against different isolates varied.

Conclusions: Children can acquire growth-inhibitory antibodies at a young age, but once they are acquired they do not appear to be boosted by on-going exposure. Inhibitory antibodies may play a role in protection from early childhood malaria.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Levels of IgG to schizont protein extract and recombinant MSP1-42, according to age and parasitemic status, among samples from the Ngerenya 1998 cohort.
A, B: Median absorbance (Optical Density, OD) to schizont protein extract and MSP1-42, respectively, for aparasitemic participants (n = 91). C, D: Median absorbance to schizont protein extract and MSP1-42, respectively, for parasitemic participants (n = 59). Sera were used at a dilution of 1∶1000. Error bars represent the inter-quartile range. P values were calculated using a Kruskal-Wallis test. All samples were tested in duplicate. The difference in median IgG levels for aparasitemic compared to parasitemic participants was not significant for schizont extract or MSP1-42 (P = 0.082 and P = 0.14, respectively).
Figure 2
Figure 2. In-vitro growth inhibition of parasite lines 3D7 and W2mef, according to parasitemic status, among samples from the Ngerenya 1998 cohort.
A, B: Mean growth of 3D7 and W2mef, respectively, for aparasitemic participants. C, D: Mean growth of 3D7 and W2mef, respectively, for parasitemic participants. Growth is expressed relative to control (PBS). Error bars represent standard deviation. P values were calculated using a one-way ANOVA. All samples were tested in duplicate in two separate assays. For all samples, including parasitemic and aparasitemic individuals together, mean growth (%, ±SD) was: W2mef (n = 138) 31.8±6.5, 2–5 years; 35.1±9.0, 6–14 years; 38.1±10.3, 18–81 years; 3D7 (n = 140) 42.4±8.3, 2–5 years; 44.2±12.4, 6–14 years; 45.4±7.5, 18–81 years.
Figure 3
Figure 3. The association between in vitro growth of parasite lines 3D7 or W2mef and IgG measured by ELISA, according to parasitemic status, for the Ngerenya 1998 cohort.
A, B: Correlation between ELISA response to schizont extract and 3D7 or W2mef growth, respectively. C, D: Correlation between ELISA response to MSP1-42 and 3D7 or W2mef growth, respectively. rs values represent Spearman's rank correlation coefficients. Results for aparasitemic and parasitemic individuals are represented by black or grey diamonds, respectively. Samples used in growth-inhibition assays were dialysed serum.
Figure 4
Figure 4. Correlation between IgG to schizont protein extract measured by ELISA and in vitro growth inhibition using purified immunoglobulins.
A 3D7 parasite line. B W2mef parasite line. Samples used in the assays were immunoglobulins purified using ammonium sulphate precipitation from Ngerenya 1998 serum samples (n = 52). rs represents Spearman's rank correlation coefficients.

References

    1. Elliott SR, Beeson JG. Estimating the burden of global mortality in children aged <5 years by pathogen-specific causes. Clin Infect Dis. 2008;46:1794–1795. - PubMed
    1. Marsh K, Kinyanjui S. Immune effector mechanisms in malaria. Parasite Immunol. 2006;28:51–60. - PubMed
    1. Cohen S, Butcher GA, Crandall RB. Action of malarial antibody in vitro. Nature. 1969;223:368–371. - PubMed
    1. Good MF, Stanisic D, Xu H, Elliott S, Wykes M. The immunological challenge to developing a vaccine to the blood stages of malaria parasites. Immunol Rev. 2004;201:254–267. - PubMed
    1. Brown GV, Anders RF, Mitchell GF, Heywood PF. Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro. Nature. 1982;297:591–593. - PubMed

Publication types

MeSH terms

Substances